---
category: news
title: "Verint partners with startup for COVID-19 contact tracing software"
excerpt: "Verint (VRNT -0.3%) and Jerusalem based Artificial Intelligence (AI) startup, Viziblezone have entered in a strategic alliance wherein the former will offer high accuracy contact tracing techn"
publishedDateTime: 2020-06-25T17:09:00Z
webUrl: "https://seekingalpha.com/news/3586249-verint-partners-startup-for-covidminus-19-contact-tracing-software"
type: article
quality: 2
heat: -1
published: false

provider:
  name: Seeking Alpha
  domain: seekingalpha.com

topics:
  - AI

related:
  - title: "Verint to Partner With Startup Viziblezone for COVID-19 Contact Tracing Software"
    excerpt: "PRNewswire/ -- Jerusalem based Artificial Intelligence (AI) startup, Viziblezone, has today announced a strategic alliance with renowned global"
    publishedDateTime: 2020-06-25T20:51:00Z
    webUrl: "https://www.prnewswire.com/il/news-releases/verint-to-partner-with-startup-viziblezone-for-covid-19-contact-tracing-software-301083763.html"
    type: article
    provider:
      name: PR Newswire
      domain: prnewswire.com
    quality: 17
    images:
      - url: "https://www.prnewswire.com/content/dam/prnewswire/common/prn_facebook_sharing_logo.jpg"
        width: 600
        height: 315
        isCached: true
  - title: "Etihad partners with Medicus AI to launch COVID-19 risk assessment tool"
    excerpt: "Etihad Airways has partnered with Austrian-based healthcare technology company Medicus AI to launch a COVID-19 risk assessment tool. Powered by Medicus AI’s technology, the risk assessment tool will guide Etihad’s passengers in evaluating the probability of having contracted the COVID19 coronavirus by responding to a set of 22 questions."
    publishedDateTime: 2020-06-28T21:09:00Z
    webUrl: "https://japantoday.com/category/features/travel/etihad-partners-with-medicus-ai-to-launch-covid-19-risk-assessment-tool"
    type: article
    provider:
      name: Japan Today
      domain: japantoday.com
    quality: 17

secured: "j8tTbdqleTTAQxdQAo92r5YjMFByCuFeFSwSAJNWtTCBsRNfu0jAT1l0MSWQ6ozDEV/uUFRAE+tFwuHOE/cjb7Fh7EhFO0BO/jsI69uYRNv9f5qeKdH7JDCFFBW3NSqxZI0jJz86o2uoyVBuQVQvC8w7OH92UcmNa1ONPqisbQ7GL4/axFJkqPwftonvKtfEY8P4cx9+uR9g5R5LZnCkD9yxO34/cFd/rGSuy90sO0Aq4Ce7f4ELYJkmYa0BM0QHa8zE1cER9OpDmF58p7CXtGlIfY5NpcFc3fK4R3N/uoLNw1nQPKd8Z1rR8X6XDViuJVVOzode/zhV7Mejt0V5nA==;OZkF3sxC2d/va6n+4WVkUw=="
---

